03 November 2020 1 Min Read

News Leader

WATCH: How Aspen secured a Covid-19 vaccine deal

Aspen Pharmacare CEO Stephen Saad talks to Business Day TV about its preliminary agreement with Johnson & Johnson

in Companies / Healthcare by Business Day TV
Stephen Saad. Picture: Bloomberg/Waldo Swiegers
Loading ...

Aspen Pharmacare has reached a preliminary agreement with Johnson & Johnson to manufacture the US company’s Covid-19 vaccine should its clinical trials prove successful. The production will be done at Aspen’s Port Elizabeth facility.

Business Day TV spoke to CEO Stephen Saad for more detail on the agreement.

Loading ...
Companies 3 years ago

Aspen bags Covid-19 vaccine deal with Johnson & Johnson

Agreement will enable drugmaker to use spare manufacturing capacity and bring down overhead costs, says CEO
Markets 3 years ago

MARKET WRAP: Aspen boosts JSE gains with biggest rise in 20 years on vaccination deal

The JSE all share gains 1.81% and the top 40 1.94%, tracking major indices as global markets recover from a one-month low
Markets 3 years ago

WATCH: Stock picks — Pepkor and Aspen

Mark du Toit from OysterCatcher Investments and Nick Kunze from Sanlam Private Wealth talk to Business Day TV
World 3 years ago

Despite Covid-19, top-end Aspen real estate is selling at a pace

The CEO of Goldman Sachs just sold a property and a vacant lot there for a combined $26.5m
Money & Investing 3 years ago

Aspen: over the worst

Aspen has spent much of the year clawing back from the brink of overindebtedness, helping its shares to a 2020 high of R154 in June. We spoke to CEO ...
Loading ...
Loading ...
View Comments